CAVEOLIN-1 Protein (CAV1)

<table class="infobox infobox-protein">
<tr><th class="infobox-header" colspan="2">Caveolin-1 Protein</th></tr>
<tr><td class="label">Protein Name</td><td>Caveolin-1 (CAV1)</td></tr>
<tr><td class="label">Gene</td><td>[CAV1](/genes/caveolin-1)</td></tr>
<tr><td class="label">UniProt</td><td><a href="https://www.uniprot.org/uniprot/P49897" target="_blank">P49897</a></td></tr>
<tr><td class="label">Molecular Weight</td><td>~22 kDa</td></tr>
<tr><td class="label">Subcellular Localization</td><td>Plasma membrane (caveolae), Endoplasmic reticulum, Golgi</td></tr>
<tr><td class="label">Protein Family</td><td>Caveolin family</td></tr>
<tr><td class="label">Tissue Specificity</td><td>Endothelial cells, adipocytes, fibroblasts, [neurons](/entities/neurons)</td></tr>
</table>

Caveolin-1 (CAV1)

Introduction

Caveolin-1 (CAV1) is a scaffolding protein that forms the structural basis of caveolae - flask-shaped invaginations of the plasma membrane involved in lipid raft organization, signal transduction, and cellular homeostasis[@rothberg1992]. Caveolin-1 plays critical roles in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) through its involvement in lipid metabolism, oxidative stress response, and neuroinflammation[@ikezu2008].

Overview

<table class="infobox infobox-protein">
<tr><th class="infobox-header" colspan="2">Caveolin-1 Protein</th></tr>
<tr><td class="label">Protein Name</td><td>Caveolin-1 (CAV1)</td></tr>
<tr><td class="label">Gene</td><td>[CAV1](/genes/caveolin-1)</td></tr>
<tr><td class="label">UniProt</td><td><a href="https://www.uniprot.org/uniprot/P49897" target="_blank">P49897</a></td></tr>
<tr><td class="label">Molecular Weight</td><td>~22 kDa</td></tr>
<tr><td class="label">Subcellular Localization</td><td>Plasma membrane (caveolae), Endoplasmic reticulum, Golgi</td></tr>
<tr><td class="label">Protein Family</td><td>Caveolin family</td></tr>
<tr><td class="label">Tissue Specificity</td><td>Endothelial cells, adipocytes, fibroblasts, [neurons](/entities/neurons)</td></tr>
</table>

Caveolin-1 (CAV1)

Introduction

Caveolin-1 (CAV1) is a scaffolding protein that forms the structural basis of caveolae - flask-shaped invaginations of the plasma membrane involved in lipid raft organization, signal transduction, and cellular homeostasis[@rothberg1992]. Caveolin-1 plays critical roles in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) through its involvement in lipid metabolism, oxidative stress response, and neuroinflammation[@ikezu2008].

Overview

The CAV1 gene encodes caveolin-1, a 22-24 kDa integral membrane protein that serves as the principal structural component of caveolae. These microdomains are enriched in cholesterol, sphingolipids, and various signaling molecules, making them crucial hubs for cellular communication. In the brain, caveolin-1 is expressed in neurons, [astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), and endothelial cells of the [blood-brain barrier](/entities/blood-brain-barrier)[@shin2019].

Structure

Caveolin-1 possesses several distinctive structural features:

The protein forms homo-oligomers of ~14-16 monomers that assemble into the characteristic caveolae structure.

Normal Function

Caveolae Formation

Caveolin-1 is essential for the formation and maintenance of caveolae:

• Organizes cholesterol and sphingolipids into microdomains
• Creates flask-shaped plasma membrane invaginations
• Facilitates endocytosis and transcytosis

Lipid Metabolism

Caveolin-1 regulates lipid homeostasis:

• Cholesterol trafficking: Controls cellular cholesterol distribution
• Lipid raft organization: Maintains membrane microdomain integrity
• Fat storage: Regulates adipocyte lipid droplets

Signal Transduction

As a scaffolding protein, caveolin-1 modulates numerous signaling pathways:

• PI3K/AKT pathway: Critical for neuronal survival
• MAPK/ERK pathway: Involved in synaptic plasticity
• [NF-κB](/entities/nf-kb) pathway: Regulates inflammatory responses

Blood-Brain Barrier Function

In brain endothelial cells, caveolin-1 maintains:

• Tight junction integrity
• Transcellular transport
• BBB selective permeability

Role in Disease

Alzheimer's Disease

Caveolin-1 plays complex roles in Alzheimer's disease pathogenesis:

• Amyloid processing: Modulates [amyloid precursor protein](/entities/app-protein) (APP) processing through [γ-secretase](/entities/gamma-secretase) localization
• [Amyloid-beta](/proteins/amyloid-beta) clearance: Influences Aβ transport across the blood-brain barrier
• Synaptic dysfunction: Alters synaptic membrane composition
• Neuroinflammation: Regulates microglial activation[@bouzioukh2021]

Parkinson's Disease

In Parkinson's disease, caveolin-1 is implicated in:

• [Alpha-synuclein](/proteins/alpha-synuclein) aggregation: Caveolae may serve as platforms for α-synuclein oligomerization
• Mitochondrial dysfunction: Alters mitochondrial cholesterol distribution
• Dopaminergic neuron survival: Modulates signaling pathways critical for neuronal viability[@jiang2020]

Amyotrophic Lateral Sclerosis (ALS)

Caveolin-1 involvement in ALS includes:

• Motor neuron vulnerability: Altered caveolae dynamics in motor neurons
• Glutamate excitotoxicity: Modulates glutamate transporter function
• Protein aggregation: Possible interaction with [TDP-43](/mechanisms/tdp-43-proteinopathy) aggregates

Stroke and Vascular Dementia

Caveolin-1 affects cerebrovascular function:

• Blood-brain barrier disruption: Increased BBB permeability in stroke
• Cerebral blood flow regulation: Controls vasodilation signaling
• Stroke outcome: Genetic variants affect stroke susceptibility

Therapeutic Targeting

Caveolin-1 represents a therapeutic target for neurodegenerative diseases:

Small Molecule Modulators

• Caveolin scaffolding domain peptides: Mimetic peptides that modulate signaling
• Statins: Indirectly affect caveolae function through cholesterol modulation

Gene Therapy Approaches

• Viral vector-mediated CAV1 overexpression
• CRISPR-based editing of CAV1 regulatory regions

Repurposed Drugs

• Tyrosine kinase inhibitors: Affect caveolin-associated signaling
• Anti-inflammatory drugs: Modulate caveolin-1 expression

Interactions

Caveolin-1 interacts with numerous proteins:

• [APP](/genes/app) (Amyloid precursor protein): Aβ processing
• [SNCA](/genes/snca) (Alpha-synuclein): Potential aggregation platform
• PI3K/AKT signaling components: Neuronal survival pathways
• Glutamate transporters (EAATs): Glutamate homeostasis
• Endothelial nitric oxide synthase (eNOS): Vascular function

Brain Regions

Caveolin-1 is expressed in:

• Cerebral [cortex](/brain-regions/cortex): Neurons and vasculature
• [Hippocampus](/brain-regions/hippocampus): Synaptic regions
• Cerebellum: Purkinje cells
• Substantia nigra: Dopaminergic neurons
• Blood-brain barrier: Endothelial cells

Background

The study of Caveolin 1 Protein (Cav1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

See Also

• [Proteins Index](/proteins)
• [Genes Index](/genes)
• [Mechanisms Index](/mechanisms)
• Lipid Raft Signaling Pathway
• Alzheimer's Disease Molecular Mechanisms
• Parkinson's Disease Pathogenesis

References